Travere Therapeutics Inc (TVTX): Kapitalflussrechnung
Kennzahl in 1000 USD | TTM 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 591.331 | 490.728 | 233.175 | 145.238 | 109.460 | 131.836 | 198.321 | 175.338 | 164.246 | 154.937 | 133.591 | 99.892 | 28.203,205 |
Cashflow aus operativer Geschäftstätigkeit | 92.700 | 37.784 | -237.475 | -280.021 | -186.291 | -14.792 | -42.743 | -58.214 | -24.958 | 7.403 | -1.596 | -554 | -45.849,75 |
▸ Operative Cashflow Marge | 15,68% | 7,7% | -101,84% | -192,8% | -170,19% | -11,22% | -21,55% | -33,2% | -15,2% | 4,78% | -1,19% | -0,55% | -162,57% |
Investitionsausgaben (CapEx) | 63.360 | 58.157 | 101.212 | 41.591 | 28.366 | 24.151 | 119.845 | 15.565 | 19.701 | 14.009 | 11.924 | 7.030 | 3.964,131 |
Cashflow aus Investitionstätigkeit | -202.986 | 27.892 | 99.325 | 55.776 | -32.553 | -137.623 | -61.327 | 19.863 | -203.291 | 45.602 | 10.370 | -80.602 | -37.262,728 |
Cashflow aus Finanzierungstätigkeit | 153.061 | -33.467 | 139.422 | 218.752 | 117.573 | 231.683 | 127.713 | -2.077 | 231.863 | 5.445 | -5.694 | 100.767 | 95.319,453 |
Freier Cashflow | 29.340 | -20.373 | -338.687 | -321.612 | -214.657 | -38.943 | -162.588 | -73.779 | -44.659 | -6.606 | -13.520 | -7.584 | -49.813,881 |
▸ Freie Cashflow Marge | 4,96% | -4,15% | -145,25% | -221,44% | -196,11% | -29,54% | -81,98% | -42,08% | -27,19% | -4,26% | -10,12% | -7,59% | -176,62% |
Ausgeschüttete Dividenden | - | - | - | - | - | - | - | - | - | - | - | - | -93.687,759 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | 27.108 | 2.112 | 2.046 | - | - | - | - | -958 | -2.257 |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.